A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer

NCT01322490 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1297

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer Metastatic

Interventions

BIOLOGICAL: PROSTVAC-V
BIOLOGICAL: PROSTVAC-F
DRUG: GM-CSF
OTHER: GM-CSF Placebo
BIOLOGICAL: Placebo

Sponsor

Bavarian Nordic